CTOs on the Move

Innovatient Solutions

www.innovatient.com

 
Innovatient helps healthcare organizations deliver better care through an interactive patient experience and engagement technology platform. The highly customizable software provides an easy-to-use solution delivered via TV, tablet, or bedside monitor engaging patients during treatment and after they go home, fostering an environment of wellness and improved outcomes. Our integrated nurse rounding, communication, and patient education tools result in improved patient satisfaction scores (HCAHPS) transforming the patient experience creating long-term relationships with healthcare providers.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Well Health

WELL is an omni-channel digital health company whose overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health. As such, WELL owns and operates primary and executive healthcare clinics in both Canada and the US, operates a global digital Electronic Medical Records (EMR) business serving thousands of healthcare clinics and health systems of all sizes and operates a multi-national portfolio of telehealth services which includes one of the largest telehealth service providers in Canada. WELL is also a provider of digital health, billing and cybersecurity related technology solutions. WELL`s wholly owned subsidiary CRH Medical provides various products and services that have supported thousands of Gastroenterology physicians in the US. WELL is an acquisitive company that follows a disciplined and accretive capital allocation strategy. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL".

Drugs.com

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Visit us at www.drugs.com.

Avaxia Biologics

Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.

AQ Safety

AQ Safety is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Total Health Care

Total Health Care, Inc. is a Detroit, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.